Transscleral Diode Laser Photocoagulation for Retinopathy of Prematurity: Five Years' Experience.
- Author:
Joon Woo PARK
1
;
Hee Joon CHO
;
Young Wook CHO
Author Information
1. Department of Ophthalmology Daegu Fatima Hospital, Daegu, Korea. ywcho2@kornet.net
- Publication Type:Original Article
- Keywords:
Transscleral diode laser photocoagulation;
Vitreous hemorrhage;
Retinopathy of prematurity
- MeSH:
Cataract;
Follow-Up Studies;
Humans;
Hyphema;
Infant;
Lasers, Semiconductor*;
Light Coagulation*;
Prognosis;
Retinopathy of Prematurity*;
Retrospective Studies;
Vitreous Hemorrhage
- From:Journal of the Korean Ophthalmological Society
2006;47(12):1960-1965
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSES: We analysed the five-year outcomes and associated complications of transscleral diode laser photocoagulation (TSDLP), used to treat acute proliferative retinopathy of prematurity (ROP), to evaluate the efficacy and safety of this therapy. METHODS: We performed a retrospective analysis of the records of 163 eyes of 82 infants with acute ROP, who were treated with TSDLP by a single surgeon. Follow-up periods ranged from 15 to 278 weeks. RESULTS: The outcome was favorable in 158 eyes (96.9%) and unfavorable in 5 eyes (3.1%) of the 163 eyes that were treated. Vitreous hemorrhage was found to be an indicator of poor prognosis. Of the complications noted, symblepharon was observed in three eyes, hyphema was observed in four eyes, and a complicated cataract was observed in one eye. CONCLUSIONS: The results suggest that TSDLP is a safe and effective in the treatment of ROP. Vitreous hemorrhage should be regarded as a sign of poor prognosis.
